Get started
ALKEM LABORATORIES LIMITEDALKEM LABORATORIES LIMITEDALKEM LABORATORIES LIMITED

ALKEM LABORATORIES LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Options

ALKEM chart


Full chart

ALKEM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪591.94 B‬ INR
Dividend yield (indicated)
0.85%
Price to earnings Ratio (TTM)
27.50
Basic EPS (TTM)
180.10 INR
Net income (FY)
‪17.96 B‬ INR
Revenue (FY)
‪125.67 B‬ INR
Shares float
‪38.91 M‬
Beta (1Y)
0.58

Employees


Employees (FY)
‪21.06 K‬
Change (1Y)
+651 +3.19%
Revenue / Employee (1Y)
‪5.97 M‬ INR
Net income / Employee (1Y)
‪852.81 K‬ INR

About ALKEM LABORATORIES LTD.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Vikas Gupta
Website
alkemlabs.com
Headquarters
Mumbai
Founded
1973
ISIN
INE540L01014
FIGI
BBG00BL0KNP1
Alkem Laboratories Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It produces branded generics, generic drugs, active pharmaceutical ingredient, and nutraceuticals. The company was founded by Samprada Singh and Basudeo Narain Singh on August 8, 1973 and is headquartered in Mumbai, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ALKEM news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ALKEM.

Frequently Asked Questions


The current price of ALKEM is 4,950.80 INR — it has decreased by −0.12% in the past 24 hours. Watch ALKEM LABORATORIES LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BSE exchange ALKEM LABORATORIES LIMITED stocks are traded under the ticker ALKEM.
ALKEM stock has risen by 2.71% compared to the previous week, the month change is a 1.96% rise, over the last year ALKEM LABORATORIES LIMITED has showed a 5.26% increase.
We've gathered analysts' opinions on ALKEM LABORATORIES LIMITED future price: according to them, ALKEM price has a max estimate of 6,150.00 INR and a min estimate of 4,350.00 INR. Watch ALKEM chart and read a more detailed ALKEM LABORATORIES LIMITED stock forecast: see what analysts think of ALKEM LABORATORIES LIMITED and suggest that you do with its stocks.
ALKEM reached its all-time high on Sep 17, 2024 with the price of 6,440.00 INR, and its all-time low was 1,175.00 INR and was reached on May 2, 2016. View more price dynamics on ALKEM chart.
See other stocks reaching their highest and lowest prices.
ALKEM stock is 2.16% volatile and has beta coefficient of 0.58. Track ALKEM LABORATORIES LIMITED stock price on the chart and check out the list of the most volatile stocks — is ALKEM LABORATORIES LIMITED there?
Today ALKEM LABORATORIES LIMITED has the market capitalization of ‪591.94 B‬, it has increased by 1.80% over the last week.
Yes, you can track ALKEM LABORATORIES LIMITED financials in yearly and quarterly reports right on TradingView.
ALKEM LABORATORIES LIMITED is going to release the next earnings report on May 29, 2025. Keep track of upcoming events with our Earnings Calendar.
ALKEM earnings for the last quarter are 52.34 INR per share, whereas the estimation was 51.24 INR resulting in a 2.15% surprise. The estimated earnings for the next quarter are 29.27 INR per share. See more details about ALKEM LABORATORIES LIMITED earnings.
ALKEM LABORATORIES LIMITED revenue for the last quarter amounts to ‪33.74 B‬ INR, despite the estimated figure of ‪34.82 B‬ INR. In the next quarter, revenue is expected to reach ‪31.30 B‬ INR.
ALKEM net income for the last quarter is ‪6.26 B‬ INR, while the quarter before that showed ‪6.89 B‬ INR of net income which accounts for −9.12% change. Track more ALKEM LABORATORIES LIMITED financial stats to get the full picture.
ALKEM LABORATORIES LIMITED dividend yield was 0.81% in 2023, and payout ratio reached 26.63%. The year before the numbers were 0.74% and 30.37% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 19, 2025, the company has ‪21.06 K‬ employees. See our rating of the largest employees — is ALKEM LABORATORIES LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALKEM LABORATORIES LIMITED EBITDA is ‪25.23 B‬ INR, and current EBITDA margin is 17.91%. See more stats in ALKEM LABORATORIES LIMITED financial statements.
Like other stocks, ALKEM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALKEM LABORATORIES LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ALKEM LABORATORIES LIMITED technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ALKEM LABORATORIES LIMITED stock shows the buy signal. See more of ALKEM LABORATORIES LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.